Neurol Clin. 1993;11:419 40. ment options. Cerebral Embolism Study Group. Stroke. 1984;15:779 89. 21. Kamalakannan D, Beeai M, Gardin JM, et al. Anticoagulation in infective endocarditis: a survey of infectious disease specialists and cardiologists. Infect Dis Clin Pract. 2005;13:122 6. 22. Nagpal A, Sohail MR, Steckelberg JM. Prosthetic valve endocarditis: state of the heart. Clin Invest. 2012;2:803 17. 23. Thuny F, Avierinos J-F, Tribouilloy C, et al. Impact of cerebrovascular com- plications on mortality and neurologic outcome during infective endocar- ditis: a prospective multicentre study. Eur Heart J. 2007;28:1155 61. 24. Duval X, Iung B, Klein I, et al. Effect of early cerebral magnetic resonance imaging on clinical decisions in infective endocarditis: a prospective study. Ann Intern Med. 2010;152:497 504, W175. 25. Iversen K, Ihlemann N, Gill SU, et al. Partial oral versus intravenous antibi- otic treatment of endocarditis. N Engl J Med. 2019;380:415 24. 26. Pruitt AA, Rubin RH, Karchmer AW, et al. Neurologic complications of bacterial endocarditis. Medicine (Baltimore). 1978;57:329 43. CLINICAL STATEMENTS AND GUIDELINES 27. Chan K-L, Tam J, Dumesnil JG, et al. Effect of long-term aspirin use on embolic events in infective endocarditis. Clin Infect Dis. 2008;46:37 41. 28. Fang MC, Go AS, Chang Y, et al. Death and disability from warfarin- associated intracranial and extracranial hemorrhages. Am J Med. 2007;120:700 5. 29. Rasmussen RV, Snygg-Martin U, Olaison L, et al. Major cerebral events in Staphylococcus aureus infective endocarditis: is anticoagulant therapy safe? Cardiology. 2009;114:284 91. 30. Sonneville R, Mirabel M, Hajage D, et al. Neurologic complications and outcomes of infective endocarditis in critically ill patients: the ENDO- cardite en REAnimation prospective multicenter study. Crit Care Med. 2011;39:1474 81. 31. Chan K-L, Dumesnil JG, Cujec B, et al. A randomized trial of aspirin on the risk of embolic events in patients with infective endocarditis. 